Volume : 08, Issue : 09, September – 2021

Title:

03.GROWING THE EFFICACY OF HYPERTENSIVE CATEGORY-II CONSUMING CURE PROCESSES PREDOMINANTLY IN THE MEXICAN INHABITANTS

Authors :

Kaynat Asghar

Abstract :

There are many reasons because of which diabetes type 2 is more prevalent. These include natural features, economic situations and educational characteristics. There is one essential cause of diabetes in Hispanic sufferers which is heredity. But these features related to heredity can never be improved. Other causes of its prevalence are social and economic aspects like less entrée to health clinics, fences of talking, artistic viewpoints and less capability related to health care giver etc. These factors should be made better to improve the treatment of diabetes type 2. At the clinical level, strategies should be made to lessen the differences among Hispanic and non-Hispanic sufferers. At physician and sufferers’ level, traditional viewpoints should be considered during the selection of suitable management strategy. By diagnosis of favored language and level of achievement for every sufferer overall organization of diabetes type 2 should be separated. These preferences need to develop the announcement by traditionally suitable learning resources and plans. Hurdles in the way of management of diabetes type 2 in Hispanic sufferers these plans may prove useful. The diabetes type 2 is more frequently present in Hispanic habitants of US as compared to non-Hispanic.
Keywords: Cultural competence; Hispanic Latino; Treatment barrier; Type 2 diabetes mellitus

Cite This Article:

Please cite this article in press Kaynat Asghar., Growing The Efficacy Of Hypertensive Category-II Consuming Cure Processes Predominantly In The Mexican Inhabitants.., Indo Am. J. P. Sci, 2021; 08(09).

Number of Downloads : 10

References:

1. Schellinger, Megan M., Mary Pell Abernathy, Barbara Amerman, Carissa May, Leslie A. Foxlow, Amy L. Carter, Kelli Barbour et al. “Improved outcomes for hispanic women with gestational diabetes using the Centering Pregnancy© Group Prenatal Care Model.” Maternal and child health journal 21, no. 2 (2017): 297-305.
2. Frias, Juan, Naunihal Virdi, Praveen Raja, Yoona Kim, George Savage, and Lars Osterberg. “Effectiveness of digital medicines to improve clinical outcomes in patients with uncontrolled hypertension and type 2 diabetes: prospective, open-label, cluster-randomized pilot clinical trial.” Journal of medical Internet research 19, no. 7 (2017): e246.
3. Avilés-Santa, M. Larissa, John Heintzman, Nangel M. Lindberg, Rafael Guerrero-Preston, Kenneth Ramos, Ana L. Abraído-Lanza, Jonca Bull et al. “Personalized medicine and Hispanic health: improving health outcomes and reducing health disparities–a National Heart, Lung, and Blood Institute workshop report.” In BMC proceedings, vol. 11, no. 11, p. 11. BioMed Central, 2017.
4. Seol, Haesun, Mark Thompson, Kathryn Evans Kreider, and Allison Vorderstrasse. “Diabetes self-management quality improvement initiative for medically underserved patients.” Journal of nursing care quality 32, no. 3 (2017): 272-279.
5. Fernández, Alicia, Judy Quan, Howard Moffet, Melissa M. Parker, Dean Schillinger, and Andrew J. Karter. “Adherence to newly prescribed diabetes medications among insured Latino and white patients with diabetes.” JAMA internal medicine 177, no. 3 (2017): 371-379.
6. Hum, Justine, Janice H. Jou, Pamela K. Green, Kristin Berry, James Lundblad, Barbara D. Hettinger, Michael Chang, and George N. Ioannou. “Improvement in glycemic control of type 2 diabetes after successful treatment of hepatitis C virus.” Diabetes care 40, no. 9 (2017): 1173-1180.
7. Hay, Joel W., Pey-Jiuan Lee, Haomiao Jin, Jeffrey J. Guterman, Sandra Gross-Schulman, Kathleen Ell, and Shinyi Wu. “Cost-effectiveness of a technology-facilitated depression care management adoption model in safety-net primary care patients with type 2 diabetes.” Value in Health 21, no. 5 (2018): 561-568.
8. Carrasquillo, Olveen, Cynthia Lebron, Yisel Alonzo, Hua Li, Aileen Chang, and Sonjia Kenya. “Effect of a community health worker intervention among Latinos with poorly controlled type 2 diabetes: the Miami Healthy Heart Initiative randomized clinical trial.” JAMA internal medicine 177, no. 7 (2017): 948-954.
9. Fortmann, Addie L., Linda C. Gallo, Maria Isabel Garcia, Mariam Taleb, Johanna A. Euyoque, Taylor Clark, Jessica Skidmore et al. “Dulce Digital: an mHealth SMS-based intervention improves glycemic control in Hispanics with type 2 diabetes.” Diabetes Care 40, no. 10 (2017): 1349-1355.
10. Rashid, Jamila R., Brenda A. Leath, Benedict I. Truman, Donna Durant Atkinson, Lisa C. Gary, and Nanmathi Manian. “Translating comparative effectiveness research into practice: Effects of interventions on lifestyle, medication adherence, and self-care for type 2 diabetes, hypertension, and obesity among black, Hispanic, and Asian residents of Chicago and Houston, 2010 to 2013.” Journal of Public Health Management and Practice 23, no. 5 (2017): 468-476.
11. Yeh, Alicia, Bijal Shah-Manek, and Kajua B. Lor. “Medication regimen complexity and A1C goal attainment in underserved adults with type 2 diabetes: a cross-sectional study.” Annals of Pharmacotherapy 51, no. 2 (2017): 111-117.
12. Pérez, A., A. Ramos, P. Reales, N. Tobares, R. Gómez-Huelgas, and Grupo de estudio AL ALTA. “Indicator performance after the implementation of the Spanish Consensus Document for the control of hyperglycemia in the hospital and at discharge.” Revista Clínica Española (English Edition) 219, no. 1 (2019): 18-25.
13. Reach, G., V. Pechtner, R. Gentilella, A. Corcos, and A. Ceriello. “Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus.” Diabetes & metabolism 43, no. 6 (2017): 501-511.
14. Kashaf, Michael Saheb, Elizabeth Tyner McGill, and Zackary Dov Berger. “Shared decision-making and outcomes in type 2 diabetes: A systematic review and meta-analysis.” Patient education and counseling 100, no. 12 (2017): 2159-2171.
15. Parker, Melissa M., Alicia Fernández, Howard H. Moffet, Richard W. Grant, Antonia Torreblanca, and Andrew J. Karter. “Association of patient-physician language concordance and glycemic control for limited–English proficiency Latinos with type 2 diabetes.” JAMA internal medicine 177, no. 3 (2017): 380-387.